In vivoAdministration of Intravenous Immunoglobulin (IVIg) can Lead to Enhanced Erythrocyte Sequestration

This publication has 18 references indexed in Scilit:

• Immune complex-like moieties in immunoglobulin for intravenous use (IVIg) bind complement and enhance phagocytosis of human erythrocytes
  Clinical and Experimental Immunology, 1998
• New therapeutic avenues in autoimmunity
  Research in Immunology, 1996
• Erythrocytes from young but not elderly donors can bind and degrade immune complex- and antibody-bound C3 in vitro
  Clinical and Experimental Immunology, 1994
• Hemolysis after high-dose intravenous Ig [letter]
  Blood, 1993
• Initial stabilization preceding enhanced hemolysis in autoimmune hemolytic anemia treated with intravenous gammaglobulin
  The Journal of Pediatrics, 1987
• Release of Immune Complexes bound to Erythrocyte Complement Receptor (CR1), with Particular Reference to the Role of Factor I
  Scandinavian Journal of Immunology, 1986
• High-dose intravenous intact IgG infusion in refractory autoimmune hemolytic anemia (Evans syndrome)
  The Journal of Pediatrics, 1985
• Lack of efficacy of high‐dose intravenous immunoglobulin in autoimmune haemolytic anaemia: a clue to its mechanism*
  Scandinavian Journal of Haematology, 1985
• EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA
  The Lancet, 1983
• Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.
  Journal of Experimental Medicine, 1982